Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for femoral neck fracture healing
NL-OMON39475Phase 3Active, not recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of teriparatide in Neck Of Femur Fracture and hip fracture, sponsored by Eli Lilly and Company. Started Nov 2011; status: active, not recruiting.
02
Drugs
teriparatide
03
Conditions
Neck Of Femur Fracturehip fracture
Beyond the preview
Go deeper on NL-OMON39475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39475.